insights_auto
Why is RNTX down 6.03%?
Dive Deeperchevron_right
RNTX:NASDAQ
Rein Therapeutics Inc
$0.80
arrow_downward
-6.03%(-0.051) 1D
$0.79
arrow_downward
-0.97% (-0.0078)bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RNTX...
Open
$0.85
High
$0.86
Low
$0.78
Mkt. cap
69.24M
Avg. vol.
471.70K
Volume
480.88K
52-wk high
$2.18
52-wk low
$0.69
EPS
-$1.59
Beta
1.36
Shares outstanding
86.27M
No. of employees
10
Open
$0.85
High
$0.86
Low
$0.78
Mkt. cap
69.24M
Avg. vol.
471.70K
Volume
480.88K
52-wk high
$2.18
52-wk low
$0.69
EPS
-$1.59
Beta
1.36
Shares outstanding
86.27M
No. of employees
10
News stories
From web sources and news partners
The Motley Fool
·
29 minutes ago
4 Stocks Delivered About Half of the S&P 500's Gain This Year
TradingView
·
6 hours ago
Nasdaq rises for the week as Lumentum leads gains
U.S. Global Investors
·
6 hours ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
marketscreener.com
·
10 hours ago
Dow's laggard, Nike disappoints again with sales and guidance
About Rein Therapeutics Inc
CEO-
Employees10
Founded2001
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitereintx.com